EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Hologic's Enterprise Value is $18,847 Mil.
Hologic's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $737 Mil. Therefore, Hologic's EV-to-EBIT for today is 25.56.
The historical rank and industry rank for Hologic's EV-to-EBIT or its related term are showing as below:
HOLX'
s EV-to-EBIT Range Over the Past 10 Years
Min: -143.59 Med: 12.78 Max: 238.3
Current: 25.56
During the past 13 years, the highest EV-to-EBIT of Hologic was 238.30. The lowest was -143.59. And the median was 12.78.
HOLX's EV-to-EBIT is ranked worse than 63.2% of 462
companies
in the Medical Devices & Instruments industry
Industry Median: 19.24
vs HOLX: 25.56
The historical data trend for Hologic's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Hologic Annual Data
Trend
Sep14
Sep15
Sep16
Sep17
Sep18
Sep19
Sep20
Sep21
Sep22
Sep23
EV-to-EBIT
-137.07
17.49
8.43
9.82
21.54
Hologic Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
EV-to-EBIT
14.47
19.88
25.49
21.54
23.61
Competitive Comparison
For the Medical Instruments & Supplies subindustry, Hologic's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hologic EV-to-EBIT Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Hologic's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Hologic's EV-to-EBIT falls into.
Hologic's current Enterprise Value is $18,847 Mil.
Hologic's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $737 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hologic (NAS:HOLX) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Hologic's Enterprise Value for the quarter that ended in Dec. 2023 was $17,404 Mil.
Hologic's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $737 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hologic EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Hologic's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (60% of total sales, boosted by pandemic), breast health (14% of sales, suppressed by pandemic), surgical (11%), and skeletal health (1%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HOLX has been successfully added to your 